Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Aussie Pharma: Path Cleared For Wesfarmers As Woolies Walks.

Aussie Pharma (API AU): Scheme Booklet Out. Meeting On The 17 March

Aussie Pharma (API AU): Sigma's Rival Bid (Just) Edges Wesfarmers

Aussie Pharm (API AU) Enters Into Scheme With Wesfarmers

Aussie Pharma (API AU): Wesfarmer's Sweetened (Yet Indicative) Offer

Quiddity Advisors

Event-Driven

Australian Pharmaceutical Industries / Event-Driven

Australian Pharmaceutical Industries (API AU)

<ul>
<li>Grocer giant <strong><a href="https://www.smartkarma.com/entities/woolworths-ltd" target="_blank" data-smartkarma-citation="entities:500:1" rel="noopener">Woolworths Ltd (WOW AU)</a></strong> has made a non-binding Offer of <a href="https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02461347-3A582711?access_token=83ff96335c2d45a094df02a206a39ff4" target="_blank" rel="noopener">A$1.75/share</a> for <a href="https://www.smartkarma.com/entities/australian-pharmaceutical-industries-limited" target="_blank" data-smartkarma-citation="entities:19399:1" rel="noopener">Australian Pharmaceutical Industries (API AU)</a>, ~12.9% above <a href="https://www.smartkarma.com/entities/wesfarmers-ltd" target="_blank" data-smartkarma-citation="entities:1104:1" rel="noopener">Wesfarmers Ltd (WES AU)</a>'s firm Offer of $1.55/share.</li>
<li>API has granted confirmatory due diligence to facilitate a binding offer. A firm Offer would be subject to ACCC approval.</li>
<li>Wesfarmers SID includes a matching right in favour of Wesfarmers which is exercisable before API enters into any binding agreement in respect of a Competing Proposal.</li>
</ul>


Grocer giant Woolworths Ltd (WOW AU) has made a non-binding Offer of A$1.75/share for Australian Pharmaceutical Industries (API AU), ~12.9% above Wesfarmers Ltd (WES AU)'s firm Offer of $1.55/share.
API has granted confirmatory due diligence to facilitate a binding offer. A firm Offer would be subject to ACCC approval.
Wesfarmers SID includes a matching right in favour of Wesfarmers which is exercisable before API enters into any binding agreement in respect of a Competing Proposal.


Washington H. Soul Pattinson and Co. Ltd (SOL AU)

Woolies Trumps Wesfarmers' Offer for Aussie Pharma